KLOW – GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg)

PEPTIDE BLENDS

Description

A four-component co-formulation supplied for controlled research environments. Suitable for studies involving peptide characterization and method development in model systems.

Composition

• GHK-Cu: 50 mg

• KPV: 10 mg

• BPC-157: 10 mg

• TB-500 (Thymosin Beta 4): 10 mg

• Appearance: lyophilized powder in a sealed research vial

Research Focus (non-clinical)

KLOW – GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB500 (10mg)

• Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems

• Assay development, including chromatographic separation of four co-formulated peptides

• Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions

• Method documentation for HPLC/LC-MS identity and purity assessments

Documentation

• COA pending — third-party verification in progress

Important Notice

• For research use only

• Not for human consumption

• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• COA pending — third-party verification in progress

• Lyophilized for transit stability; batch traceable

• Tamper-evident seal; lot & test date on each vial